Responsive image

Scientific Symposium

Exploring the Role of Biosimilars in Optimizing Treatment of Retinal Diseases

Saturday October 1, 2022 | 6:30 - 8:00 AM
Park Hyatt | 800 N Michigan Ave, Chicago, IL 60611

FACULTY PANEL

Peter Kaiser, MD

Cole Eye Institute, Cleveland Clinic
Cleveland, OH

Neil Bressler, MD

Johns Hopkins University School of Medicine
Baltimore, MD

David Brown, MD

Retina Consultants of Texas
Houston, TX

Diana Do, MD

Byers Eye Institute, Stanford University
Palo Alto, CA

Biosimilars have impacted the treatment options now available across various medical conditions. Join Biogen for an engaging breakfast panel forum as our distinguished faculty lead a discussion on the role of biosimilars, with a particular focus on wet age-related macular degeneration (AMD). The interactive faculty panel will cover several topics including real world experience and integration of biosimilars into clinical practice.

Education Objectives

  • Review the current treatment landscape for certain retinal disorders, with a focus on wet AMD
  • Evaluate the socio-economic burden of the disease from the perspectives of the patient, clinicians and payers
  • Assess how biosimilars may generate savings and efficiencies and how this may improve patient access and increased compliance
  • Explore how ophthalmologists may integrate biosimilars into clinical practice

REGISTRATION

This event is not affiliated with the official program of AAO 2022.